Literature DB >> 32817005

Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities.

Hannah Yejin Kim1,2,3, Evan Ulbricht4, Yu Kyung Ahn1, Isabelle Sarah Gillooly1, Kher Jing Lee1, Jessica Lieu1, William Nguyen1, Sylvia Young1, Jin-Gun Cho4,5,6, Jan-Willem Alffenaar1,2,3.   

Abstract

Entities:  

Year:  2021        PMID： 32817005     DOI： 10.1183/13993003.02349-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

Review 1.  Semi-Automated Therapeutic Drug Monitoring as a Pillar toward Personalized Medicine for Tuberculosis Management.

Authors:  Rannissa Puspita Jayanti; Nguyen Phuoc Long; Nguyen Ky Phat; Yong-Soon Cho; Jae-Gook Shin
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

2.  Practices of therapeutic drug monitoring in tuberculosis: an international survey.

Authors:  Ioana Margineanu; Onno Akkerman; Dario Cattaneo; Delia Goletti; Deborah J E Marriott; Giovanni Battista Migliori; Fuad Mirzayev; Charles A Peloquin; Ymkje Stienstra; Jan-Willem Alffenaar
Journal:  Eur Respir J       Date:  2022-04-14       Impact factor: 33.795

3.  Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.

Authors:  Ginger Anderson; Christopher Vinnard
Journal:  J Clin Pharmacol       Date:  2022-06-13       Impact factor: 2.860
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.